Evidence map›Paper›PMID 38006378›Full record

ArticleClinical and translational allergy2023

Asthma is associated with increased severity and duration of rhinitis: A study with the Allergic Rhinitis and its Impact on Asthma classes in the Constances cohort.

Marine Savouré, Jean Bousquet, Bénédicte Leynaert, Céline Ribet, Marcel Goldberg, Marie Zins, Bénédicte Jacquemin, Rachel Nadif

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Article
  6. Allergen Immunotherapy for the Prevention and Treatment of Asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Marine SavouréUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.ORCID https://orcid.org/0000-0003-3220-8175
Jean BousquetUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.ORCID https://orcid.org/0000-0002-4061-4766
Bénédicte LeynaertUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.ORCID https://orcid.org/0000-0001-5045-2492
Céline RibetUniversité Paris-Cité, Université Paris-Saclay, UVSQ, Inserm, UMS 11 Cohortes Epidémiologiques en population, Villejuif, France.ORCID https://orcid.org/0000-0003-2174-1126
Marcel GoldbergUniversité Paris-Cité, Université Paris-Saclay, UVSQ, Inserm, UMS 11 Cohortes Epidémiologiques en population, Villejuif, France.ORCID https://orcid.org/0000-0002-6161-5880
Marie ZinsUniversité Paris-Cité, Université Paris-Saclay, UVSQ, Inserm, UMS 11 Cohortes Epidémiologiques en population, Villejuif, France.ORCID https://orcid.org/0000-0002-4540-4282
Bénédicte JacqueminUniv Rennes, Inserm, EHESP, Irset (Institut de recherche en Santé, environnement et travail) - UMR_S 1085, Rennes, France.ORCID https://orcid.org/0000-0003-1273-9892
Rachel NadifUniversité Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.ORCID https://orcid.org/0000-0003-4938-9339
Inserm · FR

Funding

Agence de l'Environnement et de la Maîtrise de l'EnergieAgence Nationale de la RechercheCaisse nationale d'assurance maladieL'OréalMerck Sharp and DohmeUniversité Paris-Saclay
6 · The paper itself

Abstract

backgroundFew population-based studies have described allergic rhinitis (AR) according to the Allergic Rhinitis and its Impact on Asthma (ARIA) classification, and none have assessed the impact of asthma on this classification. Our aims were to 1) describe AR according to four ARIA classes and 2) within each of the four ARIA classes, compare participants with AR alone versus those with AR and asthma.

methodsCross-sectional analyses were performed using data from the 2014 annual follow-up questionnaire of the French adult population-based cohort Constances. Current AR was defined by the report of sneezing, runny, or blocked nose in the last 12 months and the report of nasal allergies. Following ARIA recommendations, rhinitis was classified according to its severity (mild or moderate-severe) and duration (intermittent or persistent). Ever asthma was also defined by a questionnaire.

resultsAmong the 4675 participants with AR (57% women, mean age 50.2 ± 12.7 years), 44% were classified as mild/intermittent, 16% mild/persistent, 25% moderate-severe/intermittent, and 15% moderate-severe/persistent. Within each of the four ARIA classes, compared to participants with rhinitis alone, participants with rhinitis and asthma had significantly more severe symptoms, more conjunctivitis, a higher mean eosinophil count and more treatments with intra-nasal corticosteroids and oral antihistamines co-medication.

conclusionsThis is a paradigm shift study as for the first time this large population-based study in adults showed that asthma status has a profound effect on the ARIA classification. Rhinitis alone and rhinitis with asthma represent two distinct phenotypes. These results reinforce the need to include asthma status in the ARIA classification and guidelines.

Indexed as

ARIAasthmadurationrhinitisseverity

Identifiers

PMID38006378
PMCPMC10668004
OpenAlexW4388991892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.